Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Cox

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Internal Medicine Journal|January 26, 2005
Isolated pulmonary hypertension in sclerodermaS R Cox, J G Walker, M Coleman, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 16, 2010
The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogsS R Cox, S P Lesman, J F Boucher, et al.
Asian Pacific Journal of Allergy and Immunology|November 30, 2004
Genomic instability in sclerodermaP J Roberts-Thomson, D A Male, J G Walker, et al.
The Journal of Pediatrics|September 1, 1995
Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosisD N Homnick, C R Spillers, S R Cox, et al.
Journal of Veterinary Pharmacology and Therapeutics|February 18, 2011
Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equineW T Collard, S R Cox, S P Lesman, et al.
The Journal of Nutrition, Health & Aging|April 22, 2022
Mediterranean-Type Diet and Brain Structural Change from 73 to 79 Years in the Lothian Birth Cohort 1936M Luciano, J Corley, M C Valdés Hernández, et al.
Psychological Medicine|June 13, 2023
White matter, cognition and psychotic-like experiences in UK BiobankM J Bosma, S R Cox, T Ziermans, et al.
Molecular Psychiatry|September 20, 2017
Genetic contributions to Trail Making Test performance in UK BiobankS P Hagenaars, S R Cox, W D Hill, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patientsA M Been-Tiktak, H M Vrehen, M M Schneider, et al.
The Journal of Infectious Diseases|November 1, 1994
Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virusR T Davey, C M Boenning, B R Herpin, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Internal Medicine Journal|January 26, 2005
Isolated pulmonary hypertension in sclerodermaS R Cox, J G Walker, M Coleman, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 16, 2010
The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogsS R Cox, S P Lesman, J F Boucher, et al.
Asian Pacific Journal of Allergy and Immunology|November 30, 2004
Genomic instability in sclerodermaP J Roberts-Thomson, D A Male, J G Walker, et al.
The Journal of Pediatrics|September 1, 1995
Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosisD N Homnick, C R Spillers, S R Cox, et al.
Journal of Veterinary Pharmacology and Therapeutics|February 18, 2011
Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equineW T Collard, S R Cox, S P Lesman, et al.
The Journal of Nutrition, Health & Aging|April 22, 2022
Mediterranean-Type Diet and Brain Structural Change from 73 to 79 Years in the Lothian Birth Cohort 1936M Luciano, J Corley, M C Valdés Hernández, et al.
Psychological Medicine|June 13, 2023
White matter, cognition and psychotic-like experiences in UK BiobankM J Bosma, S R Cox, T Ziermans, et al.
Molecular Psychiatry|September 20, 2017
Genetic contributions to Trail Making Test performance in UK BiobankS P Hagenaars, S R Cox, W D Hill, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patientsA M Been-Tiktak, H M Vrehen, M M Schneider, et al.
The Journal of Infectious Diseases|November 1, 1994
Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virusR T Davey, C M Boenning, B R Herpin, et al.
Pageof 6